INCY

Incyte Corporation

Industrials
117.25 +0.60 +0.51% Pre-Market
2026-07-17 • USD

Key Metrics

Market Cap 23.42B
EV 19.97B
Shares Out 199.78M
Revenue (ttm) 5.36B
Net Income 1.43B
Beta —
P/E —
Forward P/E —
EPS (ttm) $7.08
P/S 4.36
P/B 4.16
P/FCF 15.41
P/C 15.41
EV/Sales 3.72
EV/EBITDA 11.71
ROA 19.51%
ROE 29.24%
ROIC 23.1%
Gross Margin —
Oper. Margin 30.05%
Profit Margin 26.71%
Debt/Eq 0.00
LT Debt/Cap —
Quick Ratio 3.03
Current Ratio 3.68
Book/sh 28.21
Cash/sh 17.36
Div Yield —
Div TTM —
Payout Ratio —
SMA20 3.81%
SMA50 12.02%
SMA200 17.79%
Volume 2,190,282
Avg Volume 1.67M
Rel Volume 1.31
Perf Week 2.64%
Perf Month 19.37%
Perf Quarter 20.98%
Perf Half Y 14.26%
Perf YTD 18.71%
Perf Year 72.78%
Perf 3Y 83.17%
Perf 5Y 48.02%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Incyte is a global biopharmaceutical company engaged in the discovery, development and commercialization of proprietary therapeutics. The Company's global headquarters is in…

Name
Incyte Corporation
Industry
Industrials
CEO
William J. Meury · Chief Executive Officer
Employees
3,200 as of 2025-12-31
IPO Date
2019-01-02
Phone
(302) 498-6700
Address
1801 Augustine Cut-Off, Wilmington, DE 19803
Website
https://www.incyte.com

Key Executives

Name Title FY Pay
Jean-Jacques Bienaimé Independent Director —
Julian C. Baker Chair of the Board —
Richard Hoffman Secretary —
Hervé Hoppenot President and Former Chief Executive Officer —
William J. Meury Chief Executive Officer —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.